Morgan Stanley Lowers Price Target on Thermo Fisher Scientific to $620 From $670, Keeps Overweight Rating

robot
Abstract generation in progress

Morgan Stanley has lowered its price target for Thermo Fisher Scientific (TMO) to $620 from $670, while maintaining an Overweight rating on the stock. This adjustment comes amidst other analyst revisions, with several firms like Stifel, Leerink Partners, JPMorgan, Baird, Goldman Sachs, and Jefferies also adjusting their price targets for TMO around the same period, predominantly maintaining positive ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin